Erlotinib OMNI379 AY 22989) is a potent

AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0

Itraconazole (R51211) is a triazole antifungal agent and a potent and orally active Hedgehog (Hh) signaling pathway antagonist with an IC50 of ~800 nM

It is evolutionarily conserved and the most prominent substrate is tubulin

The antibody fragments are displayed on the surface of filamentous bacteriophage (M13)

likely mechanisms for semaglutide-induced weight loss include less appetite and food cravings

Erlotinib OMNI379 AY 22989) is a potentErlotinib (CP 358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non small cell lung cancer. Erlotinib is a click chemistry reagent, itcontains an Alkyne group and can undergo copper catalyzed azide alkyne cycloaddition (CuAAc) with molecules containing Azide groups.